Imperial College London

DR JAMES M. FLANAGAN

Faculty of MedicineDepartment of Surgery & Cancer

Reader in Epigenetics
 
 
 
//

Contact

 

+44 (0)20 7594 2127j.flanagan

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{French:2016:10.18632/oncotarget.7047,
author = {French, JD and Johnatty, SE and Lu, Y and Beesley, J and Gao, B and Kalimutho, M and Henderson, MJ and Russell, AJ and Kar, S and Chen, X and Hillman, KM and Kaufmann, S and Sivakumaran, H and O'Reilly, M and Wang, C and Korbie, DJ and Lambrechts, D and Despierre, E and Van, Nieuwenhuysen E and Lambrechts, S and Vergote, I and Karlan, B and Lester, J and Orsulic, S and Walsh, C and Fasching, PA and Beckmann, MW and Ekici, AB and Hein, A and Matsuo, K and Hosono, S and Pisterer, J and Hillemanns, P and Nakanishi, T and Yatabe, Y and Goodman, MT and Lurie, G and Matsuno, RK and Thompson, PJ and Pejovic, T and Bean, Y and Heitz, F and Harter, P and du, Bois A and Schwaab, I and Hogdall, E and Kjaer, SK and Jensen, A and Hogdall, C and Lundvall, L and Engelholm, SA and Brown, B and Flanagan, JM and Metcalf, MD and Siddiqui, N and Sellers, T and Fridley, B and Cunningham, J and Schildkraut, JM and Iversen, E and Weber, RP and Brennan, D and Berchuck, A and Pharoah, P and Harnett, P and Norr},
doi = {10.18632/oncotarget.7047},
journal = {Oncotarget},
pages = {6353--6368},
title = {Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer},
url = {http://dx.doi.org/10.18632/oncotarget.7047},
volume = {7},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - French,JD
AU - Johnatty,SE
AU - Lu,Y
AU - Beesley,J
AU - Gao,B
AU - Kalimutho,M
AU - Henderson,MJ
AU - Russell,AJ
AU - Kar,S
AU - Chen,X
AU - Hillman,KM
AU - Kaufmann,S
AU - Sivakumaran,H
AU - O'Reilly,M
AU - Wang,C
AU - Korbie,DJ
AU - Lambrechts,D
AU - Despierre,E
AU - Van,Nieuwenhuysen E
AU - Lambrechts,S
AU - Vergote,I
AU - Karlan,B
AU - Lester,J
AU - Orsulic,S
AU - Walsh,C
AU - Fasching,PA
AU - Beckmann,MW
AU - Ekici,AB
AU - Hein,A
AU - Matsuo,K
AU - Hosono,S
AU - Pisterer,J
AU - Hillemanns,P
AU - Nakanishi,T
AU - Yatabe,Y
AU - Goodman,MT
AU - Lurie,G
AU - Matsuno,RK
AU - Thompson,PJ
AU - Pejovic,T
AU - Bean,Y
AU - Heitz,F
AU - Harter,P
AU - du,Bois A
AU - Schwaab,I
AU - Hogdall,E
AU - Kjaer,SK
AU - Jensen,A
AU - Hogdall,C
AU - Lundvall,L
AU - Engelholm,SA
AU - Brown,B
AU - Flanagan,JM
AU - Metcalf,MD
AU - Siddiqui,N
AU - Sellers,T
AU - Fridley,B
AU - Cunningham,J
AU - Schildkraut,JM
AU - Iversen,E
AU - Weber,RP
AU - Brennan,D
AU - Berchuck,A
AU - Pharoah,P
AU - Harnett,P
AU - Norris,MD
AU - Haber,M
AU - Goode,EL
AU - Lee,JS
AU - Khanna,KK
AU - Meyer,KB
AU - Chenevix-Trench,G
AU - deFazio,A
AU - Edwards,SL
AU - MacGregor,S
DO - 10.18632/oncotarget.7047
EP - 6368
PY - 2016///
SN - 1949-2553
SP - 6353
TI - Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
T2 - Oncotarget
UR - http://dx.doi.org/10.18632/oncotarget.7047
UR - http://hdl.handle.net/10044/1/38514
VL - 7
ER -